£131.16

It has never been this cheap. We have no record of a lower price.

£131 today · cheaper than every other day in the last 3 months

Springer Biological and Clinical Landscape of Meningiomas: 1416 (Advances in Experimental Medicine and Biology, 1416)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days · 35 data points (no recent data)

Historical
Generating forecast…
£131.16 £124.60 £127.23 £129.85 £132.47 £135.09 £137.72 25 July 2026 02 August 2026 11 August 2026 19 August 2026 28 August 2026
View at Amazon ↗

Price data last checked 56 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 35 days • 1 price levels

Days at Price
35 days 0 9 18 26 35 £131 Days at Price

Price Analysis

Most common price: £131 (35 days, 100.0%)

Price range: £131 - £131

Price levels: 1 different prices over 35 days

Description

"Meningiomas are tumors that originate from the arachnoidal cap cells of the leptomeninges. With an incidence rate of 8.36 per 100, 000 population, they are the most common primary central nervous system (CNS) tumors, accounting for a third of all cases. The World Health Organization (WHO) classification has traditionally categorized meningiomas into 15 different histopathological subtypes and three clinical grades. Tumors are classified as WHO grades 1, 2 or 3 based largely on histopathological features such as mitotic activity, presence of brain invasion, and other atypical features. However, there is increasing recognition of the limitations of histopathology including but not limited to: confounding factors such as sampling bias in a heterogeneous tumor, and technical factors related to the experience of the grading pathologist. Even with careful histologic grading, there remains significant variability in recurrence rates within each tumor grade. As more studies have uncovered the molecular features of meningiomas, novel biological alterations have helped refine classification schemes that more accurately reflect patient outcomes. This book reviews the current state of knowledge on the genomic and epigenomic landscape of meningiomas in order to identify the roles of genomic aberrations on diagnosis, prognosis, and treatment of meningiomas in addition to mainstays of surgical management, radiation therapy, and potential novel chemotherapies. Written by a team of world-renowned experts in neurosurgery, neuropathology, radiology, and radiation-oncology, this book is the definitive resource on meningioma management and investigation for both clinicians and scientists alike."

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
29 July 2024
Listed Since
31 July 2024

Barcode

No barcode data available

Similar Products You Might Like

Current Management of Central Nervous System Meningiomas
98% match

Current Management of Central Nervous System Meningiomas

£143.75 24 Sep 2026
Surgery of Skull Base Meningiomas: With a Chapter on Pathology by G. F. Walter
98% match

Surgery of Skull Base Meningiomas: With a Chapter on Pathology by G. F. Walter

Springer

£92.22 22 Sep 2026
Meningiomas, Part II: Part II (Volume 170) (Handbook of Clinical Neurology, Volume 170)
97% match

Meningiomas, Part II: Part II (Volume 170) (Handbook of Clinical Neurology, Volume 170)

Elsevier

Price unavailable
Spinal Meningiomas
97% match

Spinal Meningiomas

Springer

£74.15 09 Sep 2026
Central Nervous System Malignancies, An Issue of Hematology/Oncology Clinics of North America: Volume 36-1 (The Clinics: Internal Medicine, Volume 36-1)
97% match

Central Nervous System Malignancies, An Issue of Hematology/Oncology Clinics of North America: Volume 36-1 (The Clinics: Internal Medicine, Volume 36-1)

Elsevier

£76.99 18 Sep 2026
Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)
97% match

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)

Humana

£155.47 27 Sep 2026
Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy
97% match

Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy

Springer

£113.09 26 Sep 2026
Neuropathology of Brain Tumors with Radiologic Correlates
96% match

Neuropathology of Brain Tumors with Radiologic Correlates

Springer

£171.73 27 Aug 2026
Tumors of the Central Nervous System - AFIP Atlas Series 4
96% match

Tumors of the Central Nervous System - AFIP Atlas Series 4

£126.15 03 Oct 2026
Meningiomas, An issue of Neurosurgery Clinics of North America (Volume 27-2) (The Clinics: Internal Medicine, Volume 27-2)
96% match

Meningiomas, An issue of Neurosurgery Clinics of North America (Volume 27-2) (The Clinics: Internal Medicine, Volume 27-2)

Elsevier

£93.81 24 Sep 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
96% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£213.71 02 Sep 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
96% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£247.78 02 Sep 2026
High-Grade Gliomas: Diagnosis and Treatment - Current Clinical Oncology
96% match

High-Grade Gliomas: Diagnosis and Treatment - Current Clinical Oncology

Humana

£75.25 13 Sep 2026
Stereotactic Radiosurgery for the Treatment of Central Nervous System Meningiomas
96% match

Stereotactic Radiosurgery for the Treatment of Central Nervous System Meningiomas

Springer

£61.84 02 Oct 2026
Diagnostic Imaging: Pediatric Neuroradiology
96% match

Diagnostic Imaging: Pediatric Neuroradiology

Elsevier

£219.83 27 Aug 2026
Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
96% match

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

Springer

£142.76 29 Sep 2026
Skull Base Surgery: Strategies
96% match

Skull Base Surgery: Strategies

Thieme

£170.23 03 Oct 2026
High-Grade Gliomas: Diagnosis and Treatment (Current Clinical Oncology)
96% match

High-Grade Gliomas: Diagnosis and Treatment (Current Clinical Oncology)

Humana

£156.70 24 Sep 2026
Osborn's Brain: Imaging, Pathology, and Anatomy
96% match

Osborn's Brain: Imaging, Pathology, and Anatomy

Elsevier

£203.97 25 Aug 2026
Brain Tumors: Their Biology and Pathology
96% match

Brain Tumors: Their Biology and Pathology

Springer

£78.84 24 Sep 2026
Advances and Technical Standards in Neurosurgery: Volume 43
96% match

Advances and Technical Standards in Neurosurgery: Volume 43

Springer

£79.99 11 Sep 2026
Malignant Brain Tumors: State-of-the-Art Treatment
96% match

Malignant Brain Tumors: State-of-the-Art Treatment

Springer

£89.28 12 Sep 2026
Skull Base Imaging: The Essentials
96% match

Skull Base Imaging: The Essentials

Springer

£104.35 24 Sep 2026
Molecular Pathology of Nervous System Tumors - Springer Medical Guide
96% match

Molecular Pathology of Nervous System Tumors - Springer Medical Guide

Springer

£99.56 17 Sep 2026